Featured Research

from universities, journals, and other organizations

Scientists See Progress In FDA Stem Cell Trial Approval

Date:
January 26, 2009
Source:
International Society for Stem Cell Research
Summary:
The International Society for Stem Cell Research shares in the excitement generated by the U.S. Food and Drug Administration's landmark decision to approve the first clinical trials using the products of human embryonic stem cells, yet advises the public to maintain realistic expectations at this early stage.

The International Society for Stem Cell Research (ISSCR) shares in the excitement generated by the U.S. Food and Drug Administration‘s landmark decision to approve the first clinical trials using the products of human embryonic stem cells, yet advises the public to maintain realistic expectations at this early stage.

A milestone for the clinical application of stem cell research, the FDA sanctioned Geron Corporation to begin trials on patients with acute spinal cord injury. The ISSCR reiterates that the Phase I trial will focus on assessing the safety of using these cells in patients, a first step of many in determining whether this treatment can provide therapeutic benefit. Regardless of outcome, the knowledge gained from the trial will provide valuable insight for future studies as researchers continue moving stem cell research into the clinic.

“The go-ahead to test products of embryonic stem cells in patients is an important first step, but only the first step on a very long journey, “ said George Q. Daley, immediate past-president of the ISSCR and associate director of the Stem Cell Program at Children’s Hospital Boston. “We have so much more to learn about stem cells, and this first trial is only the beginning. We applaud Geron’s hard work and diligence getting to this point.”

The approval comes after an extensive review process, which echoes the responsible, regulated and external evaluation procedures called for in the ISSCR Guidelines for the Clinical Translation of Stem Cells, released last month.

“This is a great time for stem cell science,” said David Scadden, co-chair of the ISSCR Clinical Translation Committee, director of the Massachusetts General Hospital Center for Regenerative Medicine, and co-director of the Harvard Stem Cell Institute. “The FDA has signaled that the safeguards are now in place to begin testing embryonic stem cell therapies. If the White House follows through with lifting restrictions on federal funding, we could see a great flowering of new research and an opportunity to see if these cells can deliver for patients.”


Story Source:

The above story is based on materials provided by International Society for Stem Cell Research. Note: Materials may be edited for content and length.


Cite This Page:

International Society for Stem Cell Research. "Scientists See Progress In FDA Stem Cell Trial Approval." ScienceDaily. ScienceDaily, 26 January 2009. <www.sciencedaily.com/releases/2009/01/090126160206.htm>.
International Society for Stem Cell Research. (2009, January 26). Scientists See Progress In FDA Stem Cell Trial Approval. ScienceDaily. Retrieved April 16, 2014 from www.sciencedaily.com/releases/2009/01/090126160206.htm
International Society for Stem Cell Research. "Scientists See Progress In FDA Stem Cell Trial Approval." ScienceDaily. www.sciencedaily.com/releases/2009/01/090126160206.htm (accessed April 16, 2014).

Share This



More Health & Medicine News

Wednesday, April 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Outbreak Now Linked To 121 Deaths

Ebola Outbreak Now Linked To 121 Deaths

Newsy (Apr. 15, 2014) The ebola virus outbreak in West Africa is now linked to 121 deaths. Health officials fear the virus will continue to spread in urban areas. Video provided by Newsy
Powered by NewsLook.com
Cognitive Function: Is It All Downhill From Age 24?

Cognitive Function: Is It All Downhill From Age 24?

Newsy (Apr. 15, 2014) A new study out of Canada says cognitive motor performance begins deteriorating around age 24. Video provided by Newsy
Powered by NewsLook.com
How Mt. Everest Helped Scientists Research Diabetes

How Mt. Everest Helped Scientists Research Diabetes

Newsy (Apr. 15, 2014) British researchers were able to use Mount Everest's low altitudes to study insulin resistance. They hope to find ways to treat diabetes. Video provided by Newsy
Powered by NewsLook.com
Carpenter's Injury Leads To Hundreds Of 3-D-Printed Hands

Carpenter's Injury Leads To Hundreds Of 3-D-Printed Hands

Newsy (Apr. 14, 2014) Richard van As lost all fingers on his right hand in a woodworking accident. Now, he's used the incident to create a prosthetic to help hundreds. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins